Try a single issue or save on a subscription Issues delivered straight to your door or device ...

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent airway blockages during sleep, leading ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Untreated sleep apnea can lead to serious health effects like heart disease. Diagnosing sleep ... Home sleep apnea tests can also help identify obstructive sleep apnea in adults suspected of ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Sleep disorders are fairly common in older adults, resulting in many getting less sleep than they need. This may be due to reasons including: medications health issues underlying sleep disorders ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.